46, XY gonadal dysgenesis is a heterogeneous disorder of sex development (DSD) that features abnormal gonadal development and varying degrees of undervirilization of the external genitalia, ranging from micropenis to female-like genitalia. Embryonic testicular regression syndrome (ETRS; MIM: 273250) is considered part of the clinical spectrum of 46,XY gonadal dysgenesis. Most ETRS patients present micropenis or atypical genitalia associated with a complete absence of gonadal tissue in one or both sides. In most patients with gonadal dysgenesis, the genetic diagnosis is unclear. We performed whole exome sequencing in ETRS patients and identified a rare variant, the p.Arg308Gln, in DEAH (Asp-Glu-Ala-His) box polypeptide 37 (DHX37) in 5 affected individuals from three unrelated families. We expanded the analysis of DHX37 coding region to additional 71 patients with 46,XY gonadal dysgenesis and identified the p.Arg308Gln and three other DHX37 missense variants (p.Arg151Trp, p.Thr304Met and p.Arg674Trp) in 11 affected members from eight distinct families (8 patients with ETRS, two with partial gonadal dysgenesis and one 46,XY DSD female patient previously gonadectomized). The p.Arg308Gln and p.Arg674Trp recurrent variants were identified in six and three families, respectively. Segregation analysis revealed sex-limited autosomal dominant inheritance in 4 families, autosomal dominant with incomplete penetrance in one family and autosomal recessive in another family. Immunohistochemical analysis of normal testes revealed that DHX37 is expressed in germ cells at different stages of maturation.
Our findings indicate that DHX37 is a new player in the complex cascade of male gonadal differentiation and maintenance, thus establishing a novel and frequent molecular etiology for 46,XY gonadal dysgenesis spectrum, mainly for embryonic testicular regression syndrome.
Introduction 46,XY gonadal dysgenesis is a heterogeneous disorder of sex development (DSD) that features abnormal gonadal development and varying degrees of undervirilization of the external genitalia, ranging from micropenis to female-like genitalia. The gonads from these patients present a wide array/spectrum of histological abnormalities, ranging from disorganized seminiferous tubules and the presence of an ovarian-like stroma, to complete absence of testicular tissue. Müllerian structures may be partially or fully developed in these patients 1 . Embryonic testicular regression syndrome (ETRS; MIM: 273250) is considered part of the clinical spectrum of 46,XY gonadal dysgenesis. Most ETRS patients present micropenis or atypical genitalia associated with a complete absence of gonadal tissue in one or both sides. The presence of micropenis suggests that functioning testes were present during early fetal development, but disappeared before birth 2, 3 .
Several genetic defects have been described in sporadic and familial forms of 46,XY gonadal dysgenesis, but the genetic etiology of most patients remains unknown [4] [5] [6] [7] [8] .
Here, we used next generation-sequencing based methods, including whole-exome sequencing and targeted gene panels, to investigate the underlying genetic etiology in a large cohort of 46,XY patients with gonadal dysgenesis of unknown cause. We identified recurrent rare variants in DEAH (Asp-Glu-Ala-His) box polypeptide 37 (DHX37) in several affected individuals from distinct families, establishing a novel genetic cause for 46,XY gonadal dysgenesis spectrum.
Ethics
This study was approved by the Ethics Committee of the Hospital das Clínicas da Faculdade de 
Subjects and Methods
Four children from two Brazilian families (Family 1 and 2) and one Chinese-American child with ETRS were firstly studied by whole-exome sequencing. Two additional families with ETRS (one from Chile, the other from Argentina) ( Table 1 and 2) and 71 Brazilian patients with sporadic 46,XY DSD (39 patients with partial and complete 46,XY gonadal dysgenesis (atypical genitalia, presence of Mullerian derivatives and/or at least one dysgenetic gonad or absence of gonadal tissue) and thirty-two 46,XY DSD patients with unknown etiology (molecular defects in LHCG and androgen receptor genes and 5ARD2 gene were ruled out by Sanger method as well as testosterone synthesis defects by hormonal evaluation) or due to previously gonadectomy. All patients have a normal GTG-banded metaphases 46,XY karyotype.
Molecular Analysis
Molecular studies were performed by targeted massively parallel sequencing or Sanger sequencing. Details of DNA extraction, Sanger and massive parallel sequencing, variant filtering and immunohistochemical staining analysis are available in the Supplementary Data.
Molecular analysis was performed on genomic DNA obtained from peripheral leukocytes. The identified allelic variants in massive parallel sequencing were subsequently confirmed by Sanger method as well as segregation analysis of the candidate variants. Allelic variants were considered to be deleterious when they were predicted to be pathogenic by at least three of the following in silico algorithms (SIFT, PolyPhen2, Mutation Taster, Mutation Assessor, FATHMM, LRT, LR score, and radial SVM) and by the conservation scores (GERP++, SiPhy, PhyloP, CADD score).
In order to select disease-causing variants, we excluded those with a minor allele frequency (> 0.5%) in publicly available population databases (gnomAD, 1000 Genomes, dbSNP, ExAC, ESP6500, ABraOM-Brazilian Genomic Variants) and in 548 Brazilian in-house controls.
Protein interaction networks (National Center for Biotechnology Information [NCBI], Biogrid, and String databases) were used to evaluate interaction among proteins which are co-expressed with DHX37 in testicular cells. Using protein interactions we constructed an hypothetical cascade of testicular differentiation including DHX37.
Histological analysis
One single pathologist (FMC) reviewed the histology of the gonadal tissue samples from all Brazilian patients.
Immunohistochemical staining study
Eight formalin-fixed paraffin-embedded testicular necropsy samples from 46,XY individuals with different chronological ages (27 and 33 weeks gestational age, 1, 53, and 180 days of age, 13, 23 and 53 years of age) were collected and used for DHX37 expression analysis by immunohistochemistry.
Statistical analysis
To provide additional genetic evidence of the association of DHX37 with gonadal dysgenesis phenotype, we performed aggregate variant analyses comparing allele frequencies between our cohort of 46,XY DSD patients and public databases (gnomAD and ABraOM). In public databases, we selected variants with similar characteristics of the DHX37 variants observed in our cohort: rare nonsynonymous variants (minor allele frequency of 0.01) located in the two highly conserved protein domains (ATP-binding and Helicase C-terminal domains) that are predicted to be pathogenic by at least four in silico tools (PROVEAN, SIFT, PolyPhen-2, and Mutation Assessor). Allele frequency differences between groups were analyzed by x2 test, and statistical significance was set at P<0.05. Statistical analyses were performed by using the SIGMAstat statistical software package (Windows version 4.0; SPSS Inc., San Rafael, CA).
Results

Exome sequencing nominated DHX37 as a candidate gene in three unrelated families.
The exome sequencing data identified the single missense DHX37 variant, c.923C>T variant is predicted to be pathogenic by six in-silico prediction sites (Table S2 ) and is not present in genomic population databases, except in the gnomAD database, where this variant was found at a very low allele frequency (0.00003) ( (Table S1 ). Three other novel variants, the c.451G>A (p.Arg151Trp), the c.911C>T
(p.Thr304Met) and the c.2020G>A (p.Arg674Trp) were identified in four distinct families:
( Table 1 Table S2 ). The p.Thr304Met
was not found in all searched population databases ( Figure 2 ; Tables S3-S4 ).
The p.Arg674Trp variant was located in the Motif VI (position 667-674), inside the Helicase superfamily c-terminal domain, and was classified as deleterious by six in silico prediction tools (Table S2 ) and was not identified in all searched population databases ( Figure 2 ; Table S3 -S4).
The p.Arg151Trp (dbSNP: rs577400960) variant was located at the beginning of the protein sequence, outside the Helicase ATP-binding, and was classified as possibly deleterious by four in silico prediction tools ( Figure 2 ; Table S2 ). It was found in heterozygous state in the 1000
Genome and in Brazilian controls with allele frequencies of 0.02% (1/5007). It was not identified in the ABraOM-Brazilian Genomic Variants and Brazilian in-house controls (Table S3 -S4).
Frequency of the DHX37 variants in our 46,XY DSD cohort
The allele frequency of rare DHX37 variants predicted to be deleterious found in our whole cohort of 46,XY DSD patients (10%) was expressively higher than that observed in individuals 
Segregation analysis revealed different inheritance patterns
Segregation analysis of the DHX37 variants in seven families displayed a sex-limited autosomal dominant pattern in three families (F2, F3, F4). In the Family 1, the presence of the p.Arg308Gln variant in the asymptomatic father suggests an autosomal dominant pattern of inheritance with incomplete penetrance. An autosomal recessive inheritance was identified in one consanguineous family (F7) ( Figure 1 ). In two sporadic cases (F5:II-1 and F7:II-1) the confirmed paternity displayed a de novo status of the p.Arg308Gln DHX37 variant ( Figure 1 ).
Absence of founder effect of DHX37 p.Arg308Gln variant
The comparative analysis of polymorphic markers located around the p.Arg308Gln variant in families 1 and 2 evaluated in exome data excluded the occurrence of founder effect.
DHX37 protein identified in different stages of germ cells maturation
To gain further insights on the role of DHX37 in testicular development, we studied its expression in testes from newborn children and from adults by immunohistochemistry technique.
DHX37 expression analysis in newborns was found exclusively in spermatogonia and it was characterized by a regular perinuclear halo pattern. The same pattern is also observed in spermatogonia of adult testis. A progressive condensation of protein around the nucleus was observed as cells changed from spermatocyte stage 1 to 2, generating a localized paranuclear pattern. A punctate perinuclear pattern of expression was observed in spermatids, but no staining was observed in spermatozoa (Figure 3 ).
Discussion
The present study analyzed a large cohort of 46,XY DSD patients without defined molecular diagnosis, most of them with gonadal dysgenesis phenotype (63%). Pathogenic allelic variants in the DHX37 was identified in 16 affected members of 11 families. Deleterious variants are recurrent in familial and sporadic cases of 46,XY GD patients from different ethnicities.
Three variants identified in the present study are located in two highly conserved domains, the Helicase ATP-binding, which is a region associated with RNA-binding activity of the RNA helicases, and the Helicase superfamily c-terminal domain, associated with ATPase activity 9 .
Rare and predicted deleterious DHX37 variants are more frequently identified in our DSD cohort (14%) than in the public databases, emphasizing that the association of DHX37 with 46,XY gonadal dysgenesis did not occur by chance (p<0.01).
Since the discovery of SRY variants in patients with gonadal dysgenesis in 1990, several genes have been associated with molecular etiology of this disorder 7 . The nuclear receptor subfamily 5 group A member 1 (NR5A1) and MAP3K1 variants are the most frequent causes of 46,XY gonadal dysgenesis [10] [11] [12] .
In this study we found an expressive frequency (10%) of likely-pathogenic variants in DHX37 in patients with 46,XY gonadal dysgenesis; considering only the ETRS phenotype (micropenis and absence of uni or bilateral testicular tissue) the frequency augmented to 50%.
The potential involvement of DHX37 in the etiology of male gonadal development defects may be supposed by reports of patients with 12q24.31-33 deletions with syndromic features and genital abnormalities 13, 14 .
DHX37 encodes an RNA helicase, which is involved in RNA-related process, including transcription, splicing, ribosome biogenesis 15, 16 , translation and degradation 17 Homozygous DHX37 mutations were previously identified by WES in affected members of two consanguineous families with neurogenetic disorders (developmental delay or intellectual disability) and brain malformations (severe microcephaly or cortical atrophy) 18 . Description of external genitalia or gonadal function of the patients with DHX37 mutations and neurogenetic disorders was not available.
Neurogenetic disorder was noticed in only one Brazilian ETRS patient, in which the homozygous p.Arg151Trp variant was identified. She was born to a consanguineous Brazilian couple and at age of 4.25 years, she had developmental delay, poor speech and short stature.
Unfortunately, her treatment was discontinued after surgery and no information about her was available. According to ACMG guidelines criteria, the p.Arg151Trp variant was classified as a variant of uncertain significance (VUS) ( Table S4 ). This variant is located outside the helicase core region and it was found in heterozygous state in low frequency (0.02%) in the 1000
Genomes Database. Although these facts suggest that the heterozygous p.Arg151Trp variant has no significant phenotypic effect, we speculate a possible pathogenic role when it is in homozygous state, similarly to previous described for mild homozygous NR5A1 mutations in 46,XY DSD patients 19, 20 . including the description of asymptomatic male members carriers of pathogenic variants of genes involved in the testicular determination as SRY and NR5A1 19, 22, 23 The heterozygous p.Arg674Trp, identified in six affected members of three unrelated families with ETRS and partial GD phenotype, was transmitted as a sex-limited autosomal dominant mode. The Residue Arg674 is located in the Motif VI, other highly conserved position of the RNA helicases of Helicase associated with ATPase activity 9 .
DEAD-box proteins have been associated to the control cellular growth, proliferation and differentiation, and are known to be implicated in embryogenesis and spermatogenesis 17, 24 . (Figure 4 ) [35] [36] [37] [38] [39] . Further studies are necessary to clarify the precise role DHX37 plays in the signaling network that regulates testicular development and maintenance.
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